Cervical Cancer Vaccine To Be Studied
A proposal to require young girls to be immunized with a new vaccine that protects against cervical cancer had the potential to be one of biggest health-care bills to pass the General Assembly this year.
Hundreds of thousands of sixth-grade girls would be protected by the drug industry's first cancer vaccine. Some strains of human papilloma virus (HPV), a widespread, sexually transmitted virus that can cause cervical cancer and genital warts, would be stopped in their tracks. This month, the Virginia General Assembly became the first legislative body in the nationy to mandate that girls receive the vaccine.
But Maryland's legislation was quickly withdrawn by its House and Senate sponsors in January. Many teachers and school administrators objected that too many students are missing school because their parents have failed to make sure they have other required immunizations.
Another reason was that Merck, the drug manufacturer that stood to earn hundreds of millions of dollars its cervical cancer vaccine, called Gardasil. Merck was lobbying heavily for passage. And lawmakers apparently were concerned that they looked like the industry was influencing them.
A bill passed both chambers this week and is now headed to Gov. Martin O'Malley's desk. But it's nothing like the original. An existing legislative committee that studies cervical cancer will create a sub-committee to study the HPV vaccine.
"The concern was that the pharmaceutical industry was pushing this more than the public health industry," explained Del. Peter A. Hammen (D-Baltimore), chairman of the House health committee. "We need to take a step back and do more deliberative work on this issue."
Posted by: District21voter | April 3, 2007 4:21 PM | Report abuse
Posted by: J J | April 3, 2007 9:18 PM | Report abuse
The comments to this entry are closed.